semaglutide injections nashville #SafetyAlert: Health officials say they are seeing an alarming rise in overdoses from weight loss drugs. ➡️ https://tinyurl.com/2yy7r2sh | WSMV 4, TennCare requesting $118M for popular

Changes coming to weight loss drug coverage benefits, effective January 1, 2025 Effective January 1, 2025, Independence Blue Cross (IBX) will no longer offer coverage for drugs including glucagon-like peptide-1 receptor antagonist (GLP-1) and non-glucagon-like peptide-1 receptor antagonist (non-GLP-1) indicated for and prescribed solely for weight loss in the absence of other FDA-approved clinical indications

Available at: obesitycanada.ca/guidelines/behavioural Pedersen S, Majoo P, Wharton S

These trials represent studies specifically designed to assess the efficacy and safety of TZP in obesity management

Injection Technique An experienced practitioner can significantly reduce discomfort by using proper technique